Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power coupled with advancements in AI technology could be utilised to revolutionise the drug development process.

Market Analysis and Insights: Global Drug Developing Platforms by Artificial Intelligence (AI) Market
The global Drug Developing Platforms by Artificial Intelligence (AI) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Developing Platforms by Artificial Intelligence (AI) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Developing Platforms by Artificial Intelligence (AI) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Developing Platforms by Artificial Intelligence (AI) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Developing Platforms by Artificial Intelligence (AI) market.

Global Drug Developing Platforms by Artificial Intelligence (AI) Scope and Market Size
Drug Developing Platforms by Artificial Intelligence (AI) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Developing Platforms by Artificial Intelligence (AI) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Software
System
Service
Product
Others

Segment by Application
Generate Data and Models
Repurpose Existing Drugs
Generate Novel Drug Candidates
Validate and Optimize Drug Candidates
Design Drugs
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Antidote
Atomwise
Turbine
Cambridge Cancer Genomics
Row Analytics
Deep Genomics
Insilico Medicine
IBM
Microsoft
Google
AiCure
Calico
Iktos
GNS Healthcare
Genpact
Biovista
NuMedii
BenevolentAI
BERG
Schrödinge
Nuritas
Exscientia
Kairntech
Concerto HealthAI (SymphonyAI)
NVIDIA Corporation
Sirenas
Standigm
Transcriptic
Cloud Pharmaceuticals
Cyclica